{"count": 8, "results": [{"_id": "36346030", "pmid": 36346030, "title": "Simvastatin and non-segmental vitiligo: A new potential treatment option?", "journal": "Dermatol Ther", "authors": ["Shaker ESE", "Allam SH", "Mabrouk MM", "Elgharbawy NM", "Salaam SFA"], "date": "2022-12-01T00:00:00Z", "doi": "10.1111/dth.15969", "meta_date_publication": "2022 Dec", "meta_volume": "35", "meta_issue": "12", "meta_pages": "e15969", "score": 50257.57, "text_hl": "We sought in this study to evaluate the influence of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @<m>DISEASE_Mouth_Diseases</m> @DISEASE_MESH:D009059 @@@vitiliginous lesions@@@ in @DISEASE_Vitiligo @DISEASE_MESH:D014820 @@@NSV@@@ @SPECIES_9606 @@@patients@@@ with @DISEASE_Dyslipidemias @DISEASE_MESH:D050171 @@@dyslipidemia@@@ and study the correlation between VIDA score and @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ profile. ", "citations": {"NLM": "Shaker ESE, Allam SH, Mabrouk MM, Elgharbawy NM, Salaam SFA. Simvastatin and non-segmental vitiligo: A new potential treatment option? Dermatol Ther. 2022 Dec;35(12):e15969. PMID: 36346030", "BibTeX": "@article{36346030, title={Simvastatin and non-segmental vitiligo: A new potential treatment option?}, author={Shaker ESE and Allam SH and Mabrouk MM and Elgharbawy NM and Salaam SFA}, journal={Dermatol Ther}, volume={35}, number={12}, pages={e15969}}"}}, {"_id": "28637327", "pmid": 28637327, "title": "Effect of simvastatin on baboon endometriosis.", "journal": "Biol Reprod", "authors": ["Taylor HS", "Alderman Iii M", "D'Hooghe TM", "Fazleabas AT", "Duleba AJ"], "date": "2017-07-01T00:00:00Z", "doi": "10.1093/biolre/iox058", "meta_date_publication": "2017 Jul 1", "meta_volume": "97", "meta_issue": "1", "meta_pages": "32-38", "score": 50067.605, "text_hl": "The volume of red, orange-red, and white @<m>DISEASE_Mouth_Diseases</m> @DISEASE_MESH:D009059 @@@endometriotic lesions@@@ was significantly reduced by 78% in animals treated with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. ", "citations": {"NLM": "Taylor HS, Alderman Iii M, D'Hooghe TM, Fazleabas AT, Duleba AJ. Effect of simvastatin on baboon endometriosis. Biol Reprod. 2017 Jul 1;97(1):32-38. PMID: 28637327", "BibTeX": "@article{28637327, title={Effect of simvastatin on baboon endometriosis.}, author={Taylor HS and Alderman Iii M and D'Hooghe TM and Fazleabas AT and Duleba AJ}, journal={Biol Reprod}, volume={97}, number={1}, pages={32-38}}"}}, {"_id": "18938217", "pmid": 18938217, "title": "Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington's disease.", "journal": "Neurosci Lett", "authors": ["Patassini S", "Giampà C", "Martorana A", "Bernardi G", "Fusco FR"], "date": "2008-12-19T00:00:00Z", "doi": "10.1016/j.neulet.2008.10.023", "meta_date_publication": "2008 Dec 19", "meta_volume": "448", "meta_issue": "1", "meta_pages": "166-9", "score": 50047.95, "text_hl": "Two more groups of animals received a pretreatment with 1mg/kg @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ i.p. for 2 weeks before the @<m>DISEASE_Mouth_Diseases</m> @DISEASE_MESH:D009059 @@@QA lesion@@@ and then were treated with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ for the following 2 weeks or 8 weeks, respectively. ", "citations": {"NLM": "Patassini S, Giampà C, Martorana A, Bernardi G, Fusco FR. Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington's disease. Neurosci Lett. 2008 Dec 19;448(1):166-9. PMID: 18938217", "BibTeX": "@article{18938217, title={Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington's disease.}, author={Patassini S and Giampà C and Martorana A and Bernardi G and Fusco FR}, journal={Neurosci Lett}, volume={448}, number={1}, pages={166-9}}"}}, {"_id": "29341259", "pmid": 29341259, "title": "CHILD syndrome mimicking verrucous nevus in a Chinese patient responded well to the topical therapy of compound of simvastatin and cholesterol.", "journal": "J Eur Acad Dermatol Venereol", "authors": ["Yu X", "Zhang J", "Gu Y", "Deng D", "Wu Z", "Bao L", "Li M", "Yao Z"], "date": "2018-07-01T00:00:00Z", "doi": "10.1111/jdv.14788", "meta_date_publication": "2018 Jul", "meta_volume": "32", "meta_issue": "7", "meta_pages": "1209-1213", "score": 50047.6, "text_hl": "The topical application of a mixed lotion containing 2% @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and 2% @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ to @<m>DISEASE_Mouth_Diseases</m> @DISEASE_MESH:D009059 @@@lesion@@@ areas based on the pathogenesis as well as the literature review. ", "citations": {"NLM": "Yu X, Zhang J, Gu Y, Deng D, Wu Z, Bao L, Li M, Yao Z. CHILD syndrome mimicking verrucous nevus in a Chinese patient responded well to the topical therapy of compound of simvastatin and cholesterol. J Eur Acad Dermatol Venereol. 2018 Jul;32(7):1209-1213. PMID: 29341259", "BibTeX": "@article{29341259, title={CHILD syndrome mimicking verrucous nevus in a Chinese patient responded well to the topical therapy of compound of simvastatin and cholesterol.}, author={Yu X and Zhang J and Gu Y and Deng D and Wu Z and Bao L and Li M and Yao Z}, journal={J Eur Acad Dermatol Venereol}, volume={32}, number={7}, pages={1209-1213}}"}}, {"_id": "23386644", "pmid": 23386644, "title": "Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells.", "journal": "J Clin Endocrinol Metab", "authors": ["Villanueva JA", "Sokalska A", "Cress AB", "Ortega I", "Bruner-Tran KL", "Osteen KG", "Duleba AJ"], "date": "2013-03-01T00:00:00Z", "doi": "10.1210/jc.2012-3387", "meta_date_publication": "2013 Mar", "meta_volume": "98", "meta_issue": "3", "meta_pages": "E455-62", "score": 50046.418, "text_hl": "CONTEXT: Growth of @<m>DISEASE_Mouth_Diseases</m> @DISEASE_MESH:D009059 @@@endometriotic lesions@@@ in rodent model of @DISEASE_Endometriosis @DISEASE_MESH:D004715 @@@endometriosis@@@ is inhibited by @CHEMICAL_Resveratrol @CHEMICAL_MESH:D000077185 @@@resveratrol@@@, a natural @CHEMICAL_Polyphenols @CHEMICAL_MESH:D059808 @@@polyphenol@@@ with antiproliferative and antiinflammatory properties, and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, an inhibitor of @GENE_HMGCR @GENE_3156 @@@3-hydroxy-3-methylglutaryl-coenzyme A reductase@@@ (@GENE_HMGCR @GENE_3156 @@@HMGCR@@@) activity. ", "citations": {"NLM": "Villanueva JA, Sokalska A, Cress AB, Ortega I, Bruner-Tran KL, Osteen KG, Duleba AJ. Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells. J Clin Endocrinol Metab. 2013 Mar;98(3):E455-62. PMID: 23386644", "BibTeX": "@article{23386644, title={Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells.}, author={Villanueva JA and Sokalska A and Cress AB and Ortega I and Bruner-Tran KL and Osteen KG and Duleba AJ}, journal={J Clin Endocrinol Metab}, volume={98}, number={3}, pages={E455-62}}"}}, {"_id": "11470468", "pmid": 11470468, "title": "Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts.", "journal": "Cardiovasc Res", "authors": ["Di Napoli P", "Antonio Taccardi A", "Grilli A", "Spina R", "Felaco M", "Barsotti A", "De Caterina R"], "date": "2001-08-01T00:00:00Z", "doi": "10.1016/s0008-6363(01)00306-6", "meta_date_publication": "2001 Aug 1", "meta_volume": "51", "meta_issue": "2", "meta_pages": "283-93", "score": 50044.418, "text_hl": "We evaluated creatinephosphokinase and @CHEMICAL_Nitrites @CHEMICAL_MESH:D009573 @@@nitrite@@@ levels in coronary effluent, heart weight changes, microvascular permeability (extravasation of @CHEMICAL_Fluorescein @CHEMICAL_MESH:D019793 @@@fluoresceine@@@-labeled albumin), ultrastructural alterations, and the expression of endothelial (e) and inducible (i) nitric oxide synthase (NOS) (by reverse-transcribed polymerase chain reaction and Western blotting) in the presence or absence of the transcriptional inhibitor @CHEMICAL_Dactinomycin @CHEMICAL_MESH:D003609 @@@actinomycin-D.@@@ RESULTS: @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ (25 microM) significantly reduced @DISEASE_Cardiomyopathies @DISEASE_MESH:D009202 @@@myocardial damage@@@ and vascular hyperpermeability, concomitant with a reduction in endothelial and @<m>DISEASE_Mouth_Diseases</m> @DISEASE_MESH:D009059 @@@cardiomyocyte lesions@@@. ", "citations": {"NLM": "Di Napoli P, Antonio Taccardi A, Grilli A, Spina R, Felaco M, Barsotti A, De Caterina R. Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts. Cardiovasc Res. 2001 Aug 1;51(2):283-93. PMID: 11470468", "BibTeX": "@article{11470468, title={Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts.}, author={Di Napoli P and Antonio Taccardi A and Grilli A and Spina R and Felaco M and Barsotti A and De Caterina R}, journal={Cardiovasc Res}, volume={51}, number={2}, pages={283-93}}"}}, {"_id": "30756034", "pmid": 30756034, "pmcid": "PMC6346926", "title": "Statin-related Lichenoid Dermatosis: An Uncommon Adverse Reaction to a Common Treatment", "journal": "Eur J Case Rep Intern Med", "authors": ["Vesza Z", "Pires C", "da Silva PM"], "date": "2018-05-25T00:00:00Z", "doi": "10.12890/2018_000844", "meta_date_publication": "2018", "meta_volume": "5", "meta_issue": "5", "meta_pages": "000844", "score": 50040.71, "text_hl": "We present the case of a 65-year-old @SPECIES_9606 @@@woman@@@ with severe @DISEASE_Hypercholesterolemia @DISEASE_MESH:D006937 @@@hypercholesterolemia@@@, who developed generalized @<m>DISEASE_Mouth_Diseases</m> @DISEASE_MESH:D009059 @@@erythematous cutaneous lesions@@@ with @DISEASE_Pruritus @DISEASE_MESH:D011537 @@@pruritus@@@, resembling @DISEASE_Lichen_Planus @DISEASE_MESH:D008010 @@@lichen planus@@@, months after starting treatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. ", "citations": {"NLM": "Vesza Z, Pires C, da Silva PM. Statin-related Lichenoid Dermatosis: An Uncommon Adverse Reaction to a Common Treatment Eur J Case Rep Intern Med. 2018;5(5):000844. PMID: 30756034", "BibTeX": "@article{30756034, title={Statin-related Lichenoid Dermatosis: An Uncommon Adverse Reaction to a Common Treatment}, author={Vesza Z and Pires C and da Silva PM}, journal={Eur J Case Rep Intern Med}, volume={5}, number={5}, pages={000844}}"}}, {"_id": "30683146", "pmid": 30683146, "pmcid": "PMC6346543", "title": "The Evaluation of Vitiligous lesions Repigmentation after the Administration of Atorvastatin calcium salt and Simvastatin-acid sodium salt in patients with active vitiligo (EVRAAS), a pilot study: study protocol for a randomized controlled trial", "journal": "Trials", "authors": ["Niezgoda A", "Winnicki A", "Kosmalski T", "Kowaliszyn B", "Krysiński J", "Czajkowski R"], "date": "2019-01-25T00:00:00Z", "doi": "10.1186/s13063-018-3168-4", "meta_date_publication": "2019 Jan 25", "meta_volume": "20", "meta_issue": "1", "meta_pages": "78", "score": 50037.043, "text_hl": "The aim of this study is to evaluate the influence of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ on @<m>DISEASE_Mouth_Diseases</m> @DISEASE_MESH:D009059 @@@vitiligous lesions@@@ in @SPECIES_9606 @@@patients@@@ with nonsegmental @DISEASE_Vitiligo @DISEASE_MESH:D014820 @@@vitiligo@@@ (@DISEASE_Vitiligo @DISEASE_MESH:D014820 @@@NSV@@@). ", "citations": {"NLM": "Niezgoda A, Winnicki A, Kosmalski T, Kowaliszyn B, Krysiński J, Czajkowski R. The Evaluation of Vitiligous lesions Repigmentation after the Administration of Atorvastatin calcium salt and Simvastatin-acid sodium salt in patients with active vitiligo (EVRAAS), a pilot study: study protocol for a randomized controlled trial Trials. 2019 Jan 25;20(1):78. PMID: 30683146", "BibTeX": "@article{30683146, title={The Evaluation of Vitiligous lesions Repigmentation after the Administration of Atorvastatin calcium salt and Simvastatin-acid sodium salt in patients with active vitiligo (EVRAAS), a pilot study: study protocol for a randomized controlled trial}, author={Niezgoda A and Winnicki A and Kosmalski T and Kowaliszyn B and Krysiński J and Czajkowski R}, journal={Trials}, volume={20}, number={1}, pages={78}}"}}]}